These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Studies of antinuclear antibodies in rheumatoid arthritis. Garcia-de la Torre I; Miranda-Mendez L J Rheumatol; 1982; 9(4):603-6. PubMed ID: 6182293 [TBL] [Abstract][Full Text] [Related]
5. [Antinuclear antibodies in defined or classical rheumatoid disease of the adult]. Cossermelli W; Leser PG; Gomide WS; Maspes V Rev Hosp Clin Fac Med Sao Paulo; 1980 Aug; 35(4):194-8. PubMed ID: 6161407 [No Abstract] [Full Text] [Related]
6. [Significance of antinuclear antibodies in rheumatoid polyarthritis in the elderly]. Moise A; Suţeanu S; Tiţeica M; Zaharescu M Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(5):457-64. PubMed ID: 2868510 [No Abstract] [Full Text] [Related]
7. [Causes of the appearance of antinuclear antibodies in patients with rheumatoid arthritis (RA)]. Chwalińska-Sadowska H; Brŭhl W; Juszczyk T; Chrzczonowski Z; Szymańska-Cygler B; Loth E; Luszczyna W; Rdułtowska H; Wagner T; Woźniczko-Orłowska G Reumatologia; 1983; 21(2):113-20. PubMed ID: 6609390 [No Abstract] [Full Text] [Related]
8. [Immunofluorescent detection of anti-RANA antigen (rheumatoid arthritis nuclear antigen) in 89 subjects, 35 of whom had rheumatoid polyarthritis]. Cohen J; Colmet-Daage JF; Blanchard F; Etienne JC; Dropsy GE; Gougeon J Rev Rhum Mal Osteoartic; 1982 Jan; 49(1):17-22. PubMed ID: 7041234 [No Abstract] [Full Text] [Related]
9. [Clinical significance of the antinuclear factor determined by the immunofluorescent method in rheumatoid arthritis]. Król W; Kolarzowska B Pol Tyg Lek; 1969 Mar; 24(11):399-400. PubMed ID: 4892175 [No Abstract] [Full Text] [Related]
11. [Immunological aspects of rheumatoid arthritis]. Feltkamp TE Ned Tijdschr Geneeskd; 1980 Oct; 124(41):1748-51. PubMed ID: 6159557 [No Abstract] [Full Text] [Related]
12. [Research on the percent of positivity of the antiperinuclear factor in rheumatoid arthritis: correlation with some clinical and sere-immunological aspects]. Damasio E; Rossi F; Viara M Reumatismo; 1967; 19(4):243-56. PubMed ID: 4876210 [No Abstract] [Full Text] [Related]
14. [Significance of anti-centromere antibodies. Clinical value]. Meyer O; Haim T; Ryckewaert A Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931 [TBL] [Abstract][Full Text] [Related]
15. [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis]. Youinou P; Le Goff P; Miossec P; Moineau MP; Ferec C Z Rheumatol; 1983; 42(1):36-9. PubMed ID: 6189305 [No Abstract] [Full Text] [Related]
16. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy. De Rycke L; Kruithof E; Van Damme N; Hoffman IE; Van den Bossche N; Van den Bosch F; Veys EM; De Keyser F Arthritis Rheum; 2003 Apr; 48(4):1015-23. PubMed ID: 12687543 [TBL] [Abstract][Full Text] [Related]
17. [Detection of antibody to rheumatoid arthritis associated nuclear antigen and its clinical significances in rheumatoid arthritis]. Li ZG; Shi GY; Cai XH Zhonghua Nei Ke Za Zhi; 1988 Oct; 27(10):630-3, 654. PubMed ID: 3068000 [No Abstract] [Full Text] [Related]
18. Immune deposits in the skin of patients with rheumatoid arthritis. McGill PE; Brougham PA; Tulloch J J Rheumatol; 1984 Aug; 11(4):454-6. PubMed ID: 6384506 [TBL] [Abstract][Full Text] [Related]
19. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis]. Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821 [TBL] [Abstract][Full Text] [Related]
20. ANA+ (anti-nuclear antibody) is correlated with RF+ (rheumatoid factor) in rheumatoid arthritis. Matsos MP; Pope JE; Spencer-Green G Inflammopharmacology; 2004; 12(3):229-31. PubMed ID: 15527547 [No Abstract] [Full Text] [Related] [Next] [New Search]